Literature DB >> 19782782

Three dimensional cancellous bone structure in hypoparathyroidism.

Mishaela R Rubin1, David W Dempster, Thomas Kohler, Martin Stauber, Hua Zhou, Elizabeth Shane, Thomas Nickolas, Emily Stein, James Sliney, Shonni J Silverberg, John P Bilezikian, Ralph Müller.   

Abstract

By conventional 2-dimensional histomorphometric analysis, we have shown that cancellous bone architecture is markedly altered in hypoparathyroidism. We have now extended these observations to a 3-dimensional analysis using microcomputed tomography. Percutaneous iliac crest bone biopsies were analyzed by high-resolution microcomputed tomography from the following 25 subjects with hypoparathyroidism: 5 postmenopausal women, 13 premenopausal women and 7 men. Thirteen living premenopausal healthy controls and 12 cadaver subjects without bone disease served as matched controls. Hypoparathyroid subjects had significantly greater bone surface density (BS/TV: 5.74+/-4.7 vs. 3.73+/-1.01 mm(2)/mm(3) [mean+/-SD]; p=0.04), trabecular thickness (Tb.Th: 0.25+/-0.19 vs. 0.17+/-0.04 mm; p=0.04), trabecular number (Tb.N: 2.99+/-3.4 vs. 1.62+/-0.39 mm(-1); p=0.05) and connectivity density (Conn.D: 16.63+/-18.7 vs. 8.39+/-5.8 mm(3); p=0.04) in comparison to matched controls. When an additional 8 hypoparathyroid (total n=33) and 24 cadaver (total cadaver n=36) subjects were added to the groups for an unmatched analysis, hypoparathyroid subjects had significantly greater cancellous bone volume (BV/TV: 26.98+/-10 vs. 15.39+/-4%; p<0.001), while trabecular separation (Tb.Sp: 0.642+/-0.10 vs. 0.781+/-0.13 mm; p<0.001) and estimation of the plate-rod characteristic (SMI: -0.457+/-1.52 vs. 0.742+/-0.51; p<0.001) were significantly lower, the latter observation implying a more plate-like trabecular structure. Variables of cancellous bone structure in the hypoparathyroid subjects, as assessed by microcomputed tomography, were highly correlated with those assessed by conventional histomorphometry. We conclude that cancellous bone in hypoparathyroidism is abnormal, suggesting that parathyroid hormone is required to maintain normal trabecular structure. The effect of these structural changes on bone strength remains to be determined. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782782      PMCID: PMC2818211          DOI: 10.1016/j.bone.2009.09.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  29 in total

1.  Mechanical consequences of bone loss in cancellous bone.

Authors:  J C van der Linden; J Homminga; J A Verhaar; H Weinans
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

2.  Quantification of Bone Microarchitecture with the Structure Model Index.

Authors:  TOR Hildebrand; PETER Rüegsegger
Journal:  Comput Methods Biomech Biomed Engin       Date:  1997       Impact factor: 1.763

3.  Structural heterogeneity in bone: good or bad?

Authors:  J Currey
Journal:  J Musculoskelet Neuronal Interact       Date:  2005 Oct-Dec       Impact factor: 2.041

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

5.  Volume and surface area measurement of viable chondrocytes in situ using geometric modelling of serial confocal sections.

Authors:  F Guilak
Journal:  J Microsc       Date:  1994-03       Impact factor: 1.758

Review 6.  Assessment of quality of bone in osteoporosis--BIOMED I: fundamental study of relevant bone.

Authors:  J Dequeker
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 7.  Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  Thyroid       Date:  2003-06       Impact factor: 6.568

8.  Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.

Authors:  Tony M Keaveny; Paul F Hoffmann; Mandeep Singh; Lisa Palermo; John P Bilezikian; Susan L Greenspan; Dennis M Black
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

9.  Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis.

Authors:  M Parisien; R W Mellish; S J Silverberg; E Shane; R Lindsay; J P Bilezikian; D W Dempster
Journal:  J Bone Miner Res       Date:  1992-08       Impact factor: 6.741

10.  Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography.

Authors:  R Müller; H Van Campenhout; B Van Damme; G Van Der Perre; J Dequeker; T Hildebrand; P Rüegsegger
Journal:  Bone       Date:  1998-07       Impact factor: 4.398

View more
  23 in total

Review 1.  Mini-review: new therapeutic options in hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; James Sliney; John P Bilezikian
Journal:  Endocrine       Date:  2012-02-07       Impact factor: 3.633

Review 2.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

3.  Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.

Authors:  John P Bilezikian; Aliya Khan; John T Potts; Maria Luisa Brandi; Bart L Clarke; Dolores Shoback; Harald Jüppner; Pierre D'Amour; John Fox; Lars Rejnmark; Leif Mosekilde; Mishaela R Rubin; David Dempster; Rachel Gafni; Michael T Collins; Jim Sliney; James Sanders
Journal:  J Bone Miner Res       Date:  2011-10       Impact factor: 6.741

4.  PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; James Sliney; Hua Zhou; Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Maryann Dellabadia; Rebecca Ives; Donald J McMahon; Chiyuan Zhang; Shonni J Silverberg; Elizabeth Shane; Serge Cremers; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

5.  Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.

Authors:  Mishaela R Rubin; John P Bilezikian
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-03

Review 6.  Use of parathyroid hormone in hypoparathyroidism.

Authors:  N E Cusano; M R Rubin; D Irani; J Sliney; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

7.  Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.

Authors:  Mishaela R Rubin; Alexander Zwahlen; David W Dempster; Hua Zhou; Natalie E Cusano; Chengchen Zhang; Ralph Müller; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2016-01-24       Impact factor: 6.741

8.  Bone mineral density in pseudohypoparathyroidism type 1a.

Authors:  Dominique N Long; Michael A Levine; Emily L Germain-Lee
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

Review 9.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

10.  Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsies.

Authors:  Patrik Christen; Keita Ito; Ralph Müller; Mishaela R Rubin; David W Dempster; John P Bilezikian; Bert van Rietbergen
Journal:  J Biomech       Date:  2012-08-09       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.